Table: Stella Pharma - 6-MTH parent results

Stella Pharma

13/11/2025 05:00

Nov 13 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2025        Sep 30, 2024      Mar 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            200 mln             169 mln           377 mln    
                 (+18.2 pct)         (+10.0 pct)       (-60.7 pct)  
  Operating     loss 298 mln        loss 269 mln      loss 922 mln  
  Recurring     loss 306 mln        loss 267 mln      loss 908 mln  
  Net           loss 307 mln        loss 268 mln      loss 911 mln  
  EPS           loss 9.05 yen       loss 8.21 yen    loss 26.80 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T